| abstract |
The present invention relates to the use of biologically active derivatives of glutarimides of the general formula (I) or their pharmaceutically acceptable salts as agents for treating eosinophilic diseases of a predominantly allergic nature, in particular bronchial asthma, allergic rhinitis, polypous rhinosinosopathy, eosinophilic colitis, eosinophilic syndrome, allergic conjunctivitis , atopic dermatitis, Cherzha-Strauss syndrome, anaphylactic shock, angioedema, eosinophilic vasculitis, eosinophilic e ofagita, eosinophilic gastroenteritis, and fibrosis; pharmaceutical compositions containing glutarimides of the general formula (I), where the meanings of the substituents R and R'and R are indicated in the claims |